Adjuvant Chemotherapy in High Risk Stage II Colon Cancer

Status Not yet recruiting

Clinical Trial Summary

- Benefit of adjuvant chemotherapy after curative surgery for stage II Colon Cancer is still debated. Several high-risk features may help to stratify stage II cancer patients into groups that will truly benefit from adjuvant chemotherapy. However, those factors are rather subjective, and no specific trial has been designed to answer the high-risk stage II colon cancer question directly.

- Immunoscore® Colon, an in vitro diagnostic test, which quantifies the density of CD3+ and CD8+ T lymphocyte populations in the center the tumor (CT) and its invasive margin (IM) using immunohistochemistry and automated image analysis. Immunoscore® has been extensively validated as a prognostic biomarker in early stage CC patients. This unique diagnostic assay measuring host immune response at the tumor site may inform the decision to administer adjuvant chemotherapy in resected Stage II and III CC patients.

- This randomized trial is studying how observation compares to adjuvant chemotherapy (investigator's choice) in stage II colon cancer patients with high-risk features and High-Immunoscore®. The trial would represent a unique opportunity to classify stage II CC patients based on their tumor microenvironment with the aim to provide efficient patient stratification to improve clinical care.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04303429
Study type	Interventional
Source	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Contact	qi li, MD,PhD
Phone	+8613818207333
Email	Leeqi2001@hotmail.com
Status	Not yet recruiting
Phase	Phase 3
Start date	August 2020
Completion date	January 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06389552` - Long-term Observational Study to Evaluate the DFS and OS of Adjuvant FOLFIRINOX Regimen in Pancreatic Cancer Patients
Recruiting	`NCT05613465` - Adjuvant Chemotherapy Plus Codonopsis Pilosula Nnannf /Placebo	N/A
Terminated	`NCT03702868` - Relationship Between Gut Microbiome and Adjuvant Chemotherapy in Patients With Early Breast Cancer
Recruiting	`NCT03748680` - IMPROVE Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer	Phase 2
Completed	`NCT03079427` - Adjuvant Capecitabine vs Gemcitabine Plus Cisplatin in Resected Extrahepatic Cholangiocarcinoma	Phase 2
Withdrawn	`NCT03228043` - Apatinib for Resectable Colorectal Cancer	N/A
Recruiting	`NCT03468010` - A Trial Comparing Adjuvant Chemotherapy With Observation After Concurrent Chemoradiotherapy of Cervical Cancer (With Pelvic or Para-aortic Node Involvement)	Phase 3
Recruiting	`NCT03199989` - Efficacy of Postoperative Adjuvant Chemotherapy for Stage II Colon Cancer With High Risk Factors(EPAC1)	Phase 3
Completed	`NCT03213444` - Impact of Adjuvant Chemotherapy in Patients With Colon Cancer	N/A
Terminated	`NCT04070313` - A Phase II Study of S-1 Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer in Taiwan	Phase 2
Recruiting	`NCT05735145` - Concurrent Chemoradiotherapy Combined With Adjuvant Chemotherapy Treated Advanced Cervical Cancer	Phase 3
Terminated	`NCT02492477` - TOP-TRIAL Safety of Not Flushing Non-used PORT-A-CATH® in Cancer Patients	Phase 1
Completed	`NCT02312284` - Observational Study on the Patients With Rectal Cancer	N/A
Active, not recruiting	`NCT04564157` - New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy	Phase 3
Recruiting	`NCT03448549` - SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients	Phase 3
Not yet recruiting	`NCT01261962` - Modulation of Immune Response by Oral Zinc Supplementation in Chemotherapy for Colon Cancer	N/A
Recruiting	`NCT01125020` - Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver Transplantation	N/A
Terminated	`NCT03858166` - Efficacy and Safety of PEG-rhG-CSF Secondary Prophylaxis vs. Therapeutic Administration in Patients With Ovarian Cancer	Phase 4
Recruiting	`NCT03748485` - Adjuvant Chemotherapy in Clinical Local Advanced CRC Following Preoperational Therapies and pT0-3N0M0 Diagnosis	N/A